Skip to main content

Pharmacy Learning Network

PharmLaw

FDA Recalls

In the News

News
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Pred Mild, prednisolone acetate ophthalmic suspension, due to failed stability specifications, affecting 2736 bottles.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
News
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug Administration (FDA) has issued a Class III recall for nicotine transdermal system patches, 14mg, due to the product’s failure to meet impurities/degradation specifications, affecting 59 808 pouches.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network
PharmLaw
06/02/2026
Grace Taylor, MS, MA
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner has been convicted of illegally distributing Schedule II opioids, according to the Department of Justice.
A Tennessee nurse practitioner...
06/02/2026
Pharmacy Learning Network
News
05/28/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug Administration (FDA) has issued a Class III recall for busulfan injections, 60mg per 10mL (6mg per mL) due to the presence of particulate matter, affecting 9528 vials.
The US Food and Drug...
05/28/2026
Pharmacy Learning Network